Galvumet

Active ingredient: Vidagliptin + Metformin

Category: Diabetes

Galvumet is a combined medicine that contains two active components 50mg of vildagliptin and 1000mg of metformin. This pharmaceutical is indicated as an adjunct to diet and exercise to improve glycaemic control in patients whose diabetes is not adequately controlled on metformin hydrochloride alone or who are already treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. Treatment should not be initiated with this fixed-dose combination. Also Galvumet is assigned in combination with a sulfonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled with metformin and a sulfonylurea. As well, Galvumet is prescribed as add-on to insulin as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Merke(r): Galvus Met / Jalra M

Produsenter: Novartis / USV

Sykdommer: Diabetes